JP2004514737A5 - - Google Patents

Download PDF

Info

Publication number
JP2004514737A5
JP2004514737A5 JP2002547480A JP2002547480A JP2004514737A5 JP 2004514737 A5 JP2004514737 A5 JP 2004514737A5 JP 2002547480 A JP2002547480 A JP 2002547480A JP 2002547480 A JP2002547480 A JP 2002547480A JP 2004514737 A5 JP2004514737 A5 JP 2004514737A5
Authority
JP
Japan
Prior art keywords
salts
proton pump
pump inhibitors
decomposable
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002547480A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004514737A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/014340 external-priority patent/WO2002045694A1/en
Publication of JP2004514737A publication Critical patent/JP2004514737A/ja
Publication of JP2004514737A5 publication Critical patent/JP2004514737A5/ja
Pending legal-status Critical Current

Links

JP2002547480A 2000-12-07 2001-12-06 酸分解性活性成分を含有する迅速に崩壊する錠剤 Pending JP2004514737A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00126807 2000-12-07
PCT/EP2001/014340 WO2002045694A1 (en) 2000-12-07 2001-12-06 Rapidly disintegrating tablet comprising an acid-labile active ingredient

Publications (2)

Publication Number Publication Date
JP2004514737A JP2004514737A (ja) 2004-05-20
JP2004514737A5 true JP2004514737A5 (cg-RX-API-DMAC7.html) 2012-04-12

Family

ID=8170591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002547480A Pending JP2004514737A (ja) 2000-12-07 2001-12-06 酸分解性活性成分を含有する迅速に崩壊する錠剤

Country Status (15)

Country Link
US (1) US7147869B2 (cg-RX-API-DMAC7.html)
EP (1) EP1341528B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004514737A (cg-RX-API-DMAC7.html)
KR (1) KR20030072555A (cg-RX-API-DMAC7.html)
CN (1) CN100335040C (cg-RX-API-DMAC7.html)
AT (1) ATE541564T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002221939A1 (cg-RX-API-DMAC7.html)
BR (1) BR0115986A (cg-RX-API-DMAC7.html)
CA (1) CA2430829C (cg-RX-API-DMAC7.html)
CY (1) CY1112615T1 (cg-RX-API-DMAC7.html)
DK (1) DK1341528T3 (cg-RX-API-DMAC7.html)
ES (1) ES2380654T3 (cg-RX-API-DMAC7.html)
PT (1) PT1341528E (cg-RX-API-DMAC7.html)
SI (1) SI1341528T1 (cg-RX-API-DMAC7.html)
WO (1) WO2002045694A1 (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
JP5009482B2 (ja) * 2000-12-07 2012-08-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸に不安定な活性成分を含有する懸濁液の形の製薬製剤
SI1341524T1 (sl) * 2000-12-07 2012-02-29 Nycomed Gmbh Farmacevtski pripravek v obliki paste, ki obsega kislinsko labilno učinkovino
EP1416922A1 (en) * 2001-07-16 2004-05-12 AstraZeneca AB Pharmaceutical formulation comprising a proton pump inhibitor and antacids
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US8057820B2 (en) * 2004-10-08 2011-11-15 Mcneil-Ppc, Inc. Enteric coated aspirin granules comingled with binder
US8758814B2 (en) * 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
ES2421916T3 (es) 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
CN100431526C (zh) * 2005-11-07 2008-11-12 上海艾力斯医药科技有限公司 一种酸敏感型药物的快速崩解片剂
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
DE202006020168U1 (de) * 2005-12-21 2008-07-17 Basf Se Pharmazeutische Formulierung für die Herstellung von schnell zerfallenden Tabletten
EP2164460B1 (de) * 2007-06-06 2017-08-09 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
EP2164462B1 (de) * 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
RU2010119041A (ru) * 2007-10-12 2011-11-20 Такеда Фармасьютикалз Норт Америка, Инк. (Us) Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи
DE102010011421A1 (de) * 2009-03-19 2010-09-30 Schaeffler Technologies Gmbh & Co. Kg Schaltbarer Schlepphebel eines Ventiltriebs einer Brennkraftmaschine
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
EP2544665A4 (en) * 2010-03-11 2014-01-01 Rich Vitamins Llc NUTRITIONAL POWDER WITH RAPID DISSOLUTION
EP2583673A1 (en) * 2010-10-14 2013-04-24 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles
EP2441446A1 (en) * 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations
JP5913367B2 (ja) 2011-01-05 2016-04-27 ホスピーラ インコーポレイテッド バンコマイシンの噴霧乾燥
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN120585773B (zh) * 2025-08-06 2025-11-07 广州仁恒医药科技股份有限公司 一种盐酸米诺环素胶囊及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065142A (en) * 1958-07-30 1962-11-20 Armour Pharma Gastric resistant medicinal preparation
US4006227A (en) * 1973-11-15 1977-02-01 Gallegos Alfred J Compositions and methods for fertility control
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
ES2202302T3 (es) * 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. Composicion masticable que libera un farmaco.
TW391880B (en) * 1994-01-31 2000-06-01 Yamanouchi Pharma Co Ltd An oral soluble type compression moulding and its preparation
SE9402431D0 (sv) 1994-07-08 1994-07-08 Astra Ab New tablet formulation
DK1078628T3 (da) 1994-07-08 2009-02-23 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
SE512835C2 (sv) 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
JP4939680B2 (ja) * 1997-05-27 2012-05-30 武田薬品工業株式会社 固形製剤
JP2001526212A (ja) * 1997-12-19 2001-12-18 スミスクライン・ビーチャム・コーポレイション 咀嚼分散性錠剤の製造法
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
PT1121103E (pt) * 1998-05-18 2007-02-28 Takeda Pharmaceutical Comprimidos de desintegração oral compreendendo um benzimidazole
ES2237121T3 (es) * 1998-07-28 2005-07-16 Takeda Pharmaceutical Company Limited Preparacion solida disgregable rapidamente.
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
DE19925710C2 (de) * 1999-06-07 2002-10-10 Byk Gulden Lomberg Chem Fab Neue Zubereitung und Darreichungsform enthaltend einen säurelabilen Protonenpumpenhemmer
EE200100660A (et) * 1999-06-07 2003-04-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake

Similar Documents

Publication Publication Date Title
CR6682A (es) Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorios, autoinmunes y respiratorias
CO5570667A2 (es) Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades
WO2005032472A3 (en) Pyrrolidine and piperidine derivatives as factor xa inhibitors
DK1569899T3 (da) Substituerede 3-alkyl- og 3-arylalkyl-1H-indol-1-yl-eddikesyrederivater som inhibitorer af plasminogenaktivator-inhibitor-1 (PAI-1)
WO2004096134A3 (en) Substituted 1,4-diazepines and uses thereof
WO2004018457A8 (en) Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
NO20071077L (no) Fosfonatanaloger til HIV-inhibitorforbindelser
WO2003047520A3 (en) SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
WO2000059902A3 (en) Aryl sulfonyls as factor xa inhibitors
EP2289894A3 (en) Pyrrolo-triazine compounds useful as kinase inhibitors
SE0202463D0 (sv) Novel compounds
ATE465146T1 (de) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
CA2260337A1 (en) Therapeutic agents
CL2008001684A1 (es) Uso de un agente estimulador seleccionado entre el grupo de acidos uronicos, mananos, sales e hidratos de los mismos y mezclas de dichos compuestos, que sirve para preparar una composicion biopesticida que comprende un microorganismo antagonista, donde dicho agente estimula las propiedades antagonistas de microorganismo antagonista. (divisional solictud 422-02)
SE9802974D0 (sv) New crystalline forms
AU2003250471A8 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
WO2000021910A3 (en) 1,2-disubstituted cyclopropanes
WO2006047528A3 (en) Pyrazolobenzamides and derivatives as factor xa inhibitors
UY26851A1 (es) Derivados de la 4-fenilpiridina
EA200501513A1 (ru) Замещённые 1, 4 - диазепины и их применения
ATE553415T1 (de) Lichtempfindliche polyimid-precursor- zusammensetzungen
DK0870763T3 (da) Kondenserede piperidinderivater som inhibitorer for syntese af nitrogenmonoxid
ATE464043T1 (de) Pharmazeutische zusammensetzung enthaltend l- arginin
DK1412343T3 (da) Forbindelser, som er stærke inhibitorer af Na+/Ca2+udbytningsmekanismen og er nyttige til behandling af arytmier
AU2003278909A1 (en) The use of benzisoselenazolone compounds against ischemic myocardial damage